Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas
Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs) are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless, despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models. However, excellent natural disease models of rapid-onset Marek's disease (MD) lymphomas in chickens allow examination of the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster, miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge, enables the prospects of generating genetically defined attenuated vaccines.
Vyšlo v časopise:
Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001305
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001305
Souhrn
Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs) are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless, despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models. However, excellent natural disease models of rapid-onset Marek's disease (MD) lymphomas in chickens allow examination of the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster, miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge, enables the prospects of generating genetically defined attenuated vaccines.
Zdroje
1. JavierRT
ButelJS
2008 The history of tumor virology. Cancer Res 68 7693 7706
2. CroceCM
2008 Oncogenes and cancer. N Engl J Med 358 502 511
3. CroceCM
2009 Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10 704 714
4. VenturaA
JacksT
2009 MicroRNAs and cancer: short RNAs go a long way. Cell 136 586 591
5. QinZ
KearneyP
PlaisanceK
ParsonsCH
2010 Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 87 25 34
6. LeiX
BaiZ
YeF
XieJ
KimCG
2010 Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12 193 199
7. CullenBR
2009 Viral and cellular messenger RNA targets of viral microRNAs. Nature 457 421 425
8. SchatKA
NairV
2008 Marek's Disease.
SaifYM
FadlyAM
GlissonJR
McDougaldLR
NolanLK
Diseases of Poultry. 12 ed Iowa Blackwell Publishing 452 514
9. CalnekBW
1986 Marek's disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol 12 293 320
10. LupianiB
LeeLF
CuiX
GimenoI
AndersonA
2004 Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101 11815 11820
11. BrownAC
BaigentSJ
SmithLP
ChattooJP
PetherbridgeLJ
2006 Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103 1687 1692
12. ZhaoY
KurianD
XuH
PetherbridgeL
SmithLP
2009 Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells. J Gen Virol 90 2201 2208
13. LupianiB
LeeLF
CuiX
GimenoI
AndersonA
2004 Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101 11815 11820
14. SuchodolskiPF
IzumiyaY
LupianiB
AjithdossDK
GiladO
2009 Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens. J Virol 83 859 869
15. BrownAC
SmithLP
KgosanaL
BaigentSJ
NairV
2009 Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J Virol 83 11142 11151
16. YaoY
ZhaoY
XuH
SmithLP
LawrieCH
2008 MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol 82 4007 4015
17. MorganR
AndersonA
BernbergE
KambojS
HuangE
2008 Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol 82 12213 12220
18. YaoY
ZhaoY
SmithLP
LawrieCH
SaundersNJ
2009 Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol 90 1551 1559
19. ZhaoY
YaoY
XuH
LambethL
SmithLP
2009 A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol 83 489 492
20. McClureLV
SullivanCS
2008 Kaposi's sarcoma herpes virus taps into a host microRNA regulatory network. Cell Host Microbe 3 1 3
21. GottweinE
MukherjeeN
SachseC
FrenzelC
MajorosWH
2007 A viral microRNA functions as an orthologue of cellular miR-155. Nature 450 1096 1099
22. MuylkensB
CoupeauD
DambrineG
TrappS
RasschaertD
2010 Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch Virol 155 1823 1837
23. TiliE
CroceCM
MichailleJJ
2009 miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28 264 284
24. FaraoniI
AntonettiFR
CardoneJ
BonmassarE
2009 miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792 497 505
25. RaiD
KimSW
McKellerMR
DahiaPL
AguiarRC
2010 Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A 107 3111 3116
26. ValeriN
GaspariniP
FabbriM
BraconiC
VeroneseA
2010 Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 107 6982 6987
27. TischerBK
von EinemJ
KauferB
OsterriederN
2006 Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40 1 6
28. LaliotiM
HeathJ
2001 A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli. Nucleic Acids Res 29 E14
29. PetherbridgeL
BrownAC
BaigentSJ
HowesK
SaccoMA
2004 Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78 13376 13380
30. ZhaoY
PetherbridgeL
SmithLP
BaigentS
NairV
2008 Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol J 5 19
31. XuH
YaoY
ZhaoY
SmithLP
BaigentSJ
2008 Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR. J Virol Methods 149 201 208
32. TamW
HughesSH
HaywardWS
BesmerP
2002 Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 76 4275 4286
33. PetherbridgeL
HowesK
BaigentSJ
SaccoMA
EvansS
2003 Replication-competent bacterial artificial chromosomes of Marek's disease virus: Novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 8712 8718
34. GottweinE
CullenBR
2008 Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3 375 387
35. XuS
XueC
LiJ
BiY
CaoY
2011 Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85 276 285
36. FaraoniI
AntonettiR
CardoneJ
BonmassarE
2009 miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta 1792 497 505
37. LuF
WeidmerA
LiuCG
VoliniaS
CroceCM
2008 Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82 10436 10443
38. BolisettyMT
DyG
TamW
BeemonKL
2009 Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol 83 12009 12017
39. SkalskyRL
SamolsMA
PlaisanceKB
BossIW
RivaA
2007 Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81 12836 12845
40. LinnstaedtSD
GottweinE
SkalskyRL
LuftigMA
CullenBR
2010 Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84 11670 11678
41. LeeEC
YuD
Martinez de VelascoJ
TessarolloL
SwingDA
2001 A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73 56 65
42. WarmingS
CostantinoN
CourtDL
JenkinsNA
CopelandNG
2005 Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33 e36
43. PrentkiP
KrischHM
1984 In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29 303 313
44. YuD
EllisHM
LeeEC
JenkinsNA
CopelandNG
2000 An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97 5978 5983
45. ZhaoY
NairV
2010 Mutagenesis of the repeat regions of herpesviruses cloned as bacterial artificial chromosomes. Methods Mol Biol 634 53 74
46. Tahiri-AlaouiA
MatsudaD
XuH
PanagiotisP
BurmanL
2009 The 5′ leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties. J Virol 83 12769 12778
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 2
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Genetic Mapping Identifies Novel Highly Protective Antigens for an Apicomplexan Parasite
- Type I Interferon Signaling Regulates Ly6C Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
- Infections in Cells: Transcriptomic Characterization of a Novel Host-Symbiont Interaction
- The ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation